AbbVie (NYSE: ABBV) today announced the successful completion of its acquisition of Apogee Therapeutics (NASDAQ: APGE), an all-cash transaction valued at approximately $10.9 billion. Under the terms...
In a strategic maneuver to solidify its presence beyond the metabolic health sector, Eli Lilly and Company (NYSE: LLY) announced on August 31, 2026, a definitive agreement to acquire Merida...
In a definitive move to dominate the rapidly expanding nuclear medicine landscape, Curium US Holdings has entered into a definitive agreement to acquire Lantheus Holdings, Inc. (NASDAQ: LNTH) for a...
AstraZeneca PLC (LON: AZN) shares fell as much as 7% in London trading on Monday, August 3, 2026, following reports that the British pharmaceutical giant has held preliminary discussions regarding a...
CAMBRIDGE, Mass. — Biogen Inc. (NASDAQ: BIIB) has signaled a definitive pivot in its capital allocation strategy following a blockbuster second quarter that saw the company swing from a projected...
TL;DR
Bayer AG announced on May 6, 2026, its acquisition of Perfuse Therapeutics for up to $2.45 billion, including a $300 million upfront payment and $2.15 billion in milestones. The deal secures...
TL;DR
Brussels-based biopharma UCB will acquire Candid Therapeutics for up to $2.2 billion, comprised of a $2.0 billion upfront cash payment and $200 million in milestones. The deal centers on...
TL;DR
Mumbai-based Sun Pharmaceutical Industries Ltd. is finalizing a binding $12 billion offer for Organon & Co., marking the largest overseas acquisition in Indian pharma history. The deal is...
TL;DR
Merck & Co. has launched a $6.7 billion all-cash unsolicited offer for Terns Pharma, a biotech firm specializing in small-molecule drug candidates for metabolic disorders like NASH. The...
TL;DR
Alcon terminated its agreement to acquire Lensar for up to $430 million on March 17, 2026, citing a protracted, year-long regulatory review by the Federal Trade Commission (FTC). The FTC...
